LIMIT Trial - Lidocaine With Intramuscular Injection of Benzathine Penicillin G for Treponema Pallidum Treatment

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorWashington University School of Medicine

About this trial

There is evidence to suggest that lidocaine can help reduce the pain associated with intramuscular injections of benzathine penicillin G (BPG) or Bicillin, used to treat syphilis infections. A study published in the Journal of Family Practice in 2001 compared the pain experienced during bicillin injections with and without the use of lidocaine. The study found that patients who received lidocaine injections before receiving bicillin reported significantly less pain compared to those who received bicillin injections without lidocaine. Per the International Union against Sexually Transmitted Infections (IUSTI) European Guidelines for syphilis management, lidocaine has been used as a diluent for BPG since 1998. In the United States (US), BPG often comes prepackaged and lidocaine is unable to be used as a diluent with the same ease as it is in Europe. In light of this, the investigators propose a randomized controlled trial of benzathine penicillin G with and without lidocaine to quantify any site pain reduction with lidocaine in patients being treated for syphilis.

This study is a randomized, double blinded, placebo controlled trial. During this study, patients needing BPG treatment for syphilis will be screened for any penicillin allergies and consented to their participation. Each participant will receive 2 injections of BPG, 1.2 million units each (2x1.2 million units = 2.4 million units, the standard dose for syphilis treatment), as intramuscular injections, one in each gluteal muscle, with one of the injections randomly having 0.5ml of 1% lidocaine added while the other has 0.5 ml normal saline solution. The side of each injection will be randomized by the medical assistant (MA)/nurse filling the vials and the injecting MA will be blinded, as well as the study participant, as to which vial contains lidocaine and which contains normal saline. The participants will then be asked to rate their pain from 0-10 on each site of injection at 10 minutes post injection, then again at 24 hours after injection via email electronic survey (via RedCap). The differences in pain from the two injections will be compared and analyzed to see if lidocaine reduces pain associated with BPG injections compared to the control of normal saline added to BPG.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults 18 years of age or above

Confirmed syphilis diagnosis (reactive RPR with confirmatory treponemal testing)

Receiving first injection in series if patient requires 3x weekly injections for syphilis treatment

Disqualifiers

Penicillin allergy (anaphylaxis)

Lidocaine allergy (anaphylaxis)

Second or third injection in series if patient requires 3x weekly injections for syphilis treatment

Pregnancy

Trial design

Design model

Crossover

Treatments tested in this trial

  • normal Saline

    Drug

    0.5ml normal saline solution added to prefilled 1.2 million units Benzathine Pencillin G syringe

  • Lidocaine

    Drug

    0.5ml 1% lidocaine solution added to prefilled 1.2 million units Benzathine Pencillin G syringe

Treatment groups

48 Participants
are divided into 2 treatment groups
Group A: Lidocaine + Benzathine Penicillin G ArmExperimental treatment 1 intervention
Group B: Normal Saline + Benzthine Penicillin G ArmPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Mean Pain Score (0-10) of Benzathine Penicillin G + Lidocaine Injection 10 minutes post injection

The average rating of participants' injection site pain with added lidocaine from 0 (no pain) to 10 (extreme pain) at 10 minutes post injection

Time frame
10 minutes
2

Mean Pain Score (0-10) of Benzathine Penicillin G + Saline Injection 10 minutes post injection

The average rating of participants' injection site pain with added lidocaine from 0 (no pain) to 10 (extreme pain) at 10 minutes post injection

Time frame
10 minutes
3

Relative difference of mean pain scores between injection types 10 minutes post injection

Comparative t-test of means of pain scores at injections sites at 10 minutes post injection

Time frame
10 minutes
4

Mean Pain Score (0-10) of Benzathine Penicillin G + Lidocaine Injection 24 hours post injection

The average rating of participants' injection site pain with added lidocaine from 0 (no pain) to 10 (extreme pain) at 24 hourspost injection

Time frame
24 hours

Secondary outcomes

1

Rate of Adverse reactions

To see if there are any adverse effects of adding 0.5 ml 1% lidocaine to prepackaged Benzathine Penicillin G

Time frame
7 days
2

Rate of Use of other pain medications

To assess use of other pain medications 24 hours post injection.

Time frame
24 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.